title: CYP2C19 genotype and outcomes of clopidogrel treatment.
authors.forename: Tobias
authors.initials: T
authors.lastname: Geisler
authors.forename: Boris
authors.initials: B
authors.lastname: Bigalke
authors.forename: Matthias
authors.initials: M
authors.lastname: Schwab
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D005838:Genotype; D006801:Humans; D009154:Mutation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine